04/25/2024
3:26 PM | BioCryst Pharmaceuticals (Filer)
| Form ARS | |
04/02/2024
3:21 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:32 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:02 AM | Avoro Capital Advisors LLC (Filed by)
BioCryst Pharmaceuticals (Subject)
| Form SC 13G | |
01/24/2024
4:23 PM | BioCryst Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024
12:06 PM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
|
01/18/2024
4:21 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:42 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:33 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:35 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:38 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:43 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:47 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:34 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:37 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:42 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
6:37 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
8:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
3:29 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/03/2023
11:14 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
11:16 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2023
8:36 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
3:41 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:43 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
6:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
6:00 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
6:33 AM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:42 PM | BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:43 PM | BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:50 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:31 PM | BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:33 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:35 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:37 PM | BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Move Your Money Before May 22 (Ad) The SIX WORDS That Could Destroy America... And The Value of Your Savings.
He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.  Here's where Dr. David Eifrig says to move your money immediately. |
06/15/2023
3:39 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:28 PM | ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:29 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
9:19 AM | BioCryst Pharmaceuticals (Subject)
SANDERS MACHELLE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
10:32 AM | BioCryst Pharmaceuticals (Subject)
Hutson Nancy J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
3:32 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
6:08 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
